Follow-Up Schedule After Reducing Rexulti (Brexpiprazole) Dose in Previously Unstable Patients
Rationale for Early Follow-Up
- The first follow-up visit after dose reduction should occur within 1-2 weeks for higher-risk patients who were previously unstable, as this timeframe allows for early detection of symptom recurrence or adverse effects 1
- For psychiatric medications with faster onset of action changes (like Rexulti), an early follow-up within 4 weeks is recommended to assess medication effects and tolerability 1
Assessment During Follow-Up Visit
- Evaluate for return or worsening of psychiatric symptoms using standardized rating scales to objectively measure symptom changes 1
- Review medication adherence and any barriers to consistent use that may have developed 1
Subsequent Follow-Up Schedule
- If the patient remains stable at the first follow-up, schedule the next visit in 4-6 weeks 1
- Once stability is confirmed over 2-3 months, follow-up frequency can be extended to every 2-3 months 2
- More frequent monitoring may be needed if any concerning symptoms or side effects emerge 1
Special Considerations
- For patients with comorbid medical conditions, coordinate follow-up with other healthcare providers to ensure comprehensive care 1
- If the patient shows signs of clinical worsening at any point, immediate reassessment is warranted rather than waiting for the scheduled follow-up 1
Monitoring Parameters
- At each follow-up visit, assess psychiatric symptom severity using validated rating scales 1
Adjusting the Treatment Plan
- If symptoms worsen after dose reduction, consider returning to the previous effective dose 1
- If the reduced dose is well-tolerated with maintained symptom control after 3-6 months, the current regimen can be continued 2
- Document the patient's response to dose reduction to guide future treatment decisions 1